FDA builds STED programme with impressive product range
This article was originally published in Clinica
Executive Summary
The FDA has included an impressive list of advanced medical products that will qualify for participation in its newly-announced pilot programme testing the use of an internationally harmonised format and content for premarket submissions. Included on the list are coronary stents, implantable cardioverter defibrillators and magnetic resonance imaging devices.